Atorvastatin Calcium
Product Images NDC 70934-070

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 069 90 Rev A 01 19

This is a description of medication for Atorvastatin Calcium Tablets in 20mg strength. The medication is available in a package size of 20 tablets. The NDC number is 70934-068-90. The rest of the text appears to be incomplete or gibberish.*

FDA Label Image

Label 1 (70934 070 30 Rev A 01 18)

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

The text appears to be a chart or diagram showing the cumulative incidence percentages for a certain time period. It also includes a hazard ratio (HR) and p-value. The exact context and interpretation of the data cannot be determined without further information.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

This is a graph that shows the cumulative hazard percentage over a period of 4 years based on a certain primary endpoint. The hazard percentages are shown for 5 different time points. The hazard ratio (HR) is also provided, which indicates a 37% decrease in the risk of the primary endpoint over the course of 4 years with a p-value of 0.001.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

The text describes a study in which subjects were given different doses of Atorvastatin (10mg and 80mg). The table given shows the percentage of subjects experiencing a cardiovascular event over time. The results suggest that the group given Atorvastatin 80mg had a lower risk of experiencing a cardiovascular event compared to the group given Atorvastatin 10mg. The hazard ratio and p-value for this difference are also given. However, given the limited information available, it is difficult to determine the specific cardiovascular outcomes or characteristics of the study population.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.